Event DetailsEvent Details

With Japan facing increasing pressure to balance healthcare affordabilitywith innovation, challenges such as drug lag and pricing policies are more critical than ever. As the global pharmaceutical landscape evolves and healthcare demands grow and technological advancements accelerate, Japan must navigate these issues to remain competitive and foster advancements in healthcare.

The BCCJ invites you to a timely lunchtime event on Thursday, February 6 at the AstraZeneca KK office, examining the current and future state of drug development and approval in Japan, and how this compares to the UK. Our panel of experts will explore how regulatory frameworks, innovation ecosystems, public-private partnerships, and international collaboration can address these pressing challenges and unlock new opportunities.


This event is designed for industry professionals, policymakers, researchers, and anyone interested in the future of healthcare in Japan and synergies in healthcare innovation between Japan and the UK.

SpeakersSpeakers

HighlightsHighlights

4Speakers

VenueVenue

AstraZeneca

Minato City, Tokyo, Japan

Contact

If you have any questions please contact Sam Maddicott at maddicott@bccjapan.com.

Sponsors and PartnersSponsors and Partners

Organizer

TicketsTickets

Free Admittance

Individual Ticket
  • Standard PriceComplimentary

CommunityCommunity

Discover and connect with other attendees.